norfloxacin has been researched along with Campylobacter Infection in 12 studies
Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Its efficacy for the treatment of human campylobacteriosis should be evaluated in clinical trials." | 1.36 | Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents. ( Hakanen, AJ; Huovinen, P; Kotilainen, P; Lehtopolku, M; Nakari, UM; Siitonen, A, 2010) |
| "In a patient with campylobacteriosis, we observed development of resistance to nalidixic acid and norfloxacin under adequate treatment with the latter antibiotic." | 1.27 | Problems in identification of Campylobacter jejuni associated with acquisition of resistance to nalidixic acid. ( Altwegg, M; Burnens, A; Penner, JL; Zollinger-Iten, J, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (25.00) | 18.7374 |
| 1990's | 6 (50.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Lehtopolku, M | 1 |
| Nakari, UM | 1 |
| Kotilainen, P | 1 |
| Huovinen, P | 1 |
| Siitonen, A | 1 |
| Hakanen, AJ | 1 |
| Hagos, Y | 1 |
| Gugsa, G | 1 |
| Awol, N | 1 |
| Ahmed, M | 1 |
| Tsegaye, Y | 1 |
| Abebe, N | 1 |
| Bsrat, A | 1 |
| Baird, RW | 1 |
| Sjögren, E | 2 |
| Lindblom, GB | 1 |
| Kaijser, B | 2 |
| Chuma, T | 1 |
| Ikeda, T | 1 |
| Maeda, T | 1 |
| Niwa, H | 1 |
| Okamoto, K | 1 |
| Wretlind, B | 1 |
| Strömberg, A | 1 |
| Ostlund, L | 1 |
| Adler-Mosca, H | 1 |
| Lüthy-Hottenstein, J | 1 |
| Martinetti Lucchini, G | 1 |
| Burnens, A | 2 |
| Altwegg, M | 2 |
| Fujii, R | 1 |
| Meguro, H | 1 |
| Arimasu, O | 1 |
| Ushijima, K | 1 |
| Abe, T | 1 |
| Nakazawa, S | 1 |
| Sato, H | 1 |
| Narita, A | 1 |
| Niino, K | 1 |
| Ichihashi, H | 1 |
| Minamitani, M | 1 |
| Hachimori, K | 1 |
| Kaneda, K | 1 |
| Mertens, JC | 1 |
| Dekker, W | 1 |
| Ligtvoet, EE | 1 |
| Blok, P | 1 |
| Aoki, T | 1 |
| Shimizu, N | 1 |
| Tomizawa, I | 1 |
| Takizawa, Y | 1 |
| Matsubara, Y | 1 |
| Seo, T | 1 |
| Sagara, H | 1 |
| Tagawa, K | 1 |
| Masuda, G | 1 |
| Negishi, M | 1 |
| Zollinger-Iten, J | 1 |
| Penner, JL | 1 |
2 trials available for norfloxacin and Campylobacter Infection
| Article | Year |
|---|---|
Rapid emergence of quinolone resistance in Campylobacter jejuni in patients treated with norfloxacin.
Topics: Adult; Campylobacter Infections; Campylobacter jejuni; Double-Blind Method; Drug Resistance, Microbi | 1992 |
[Evaluation of norfloxacin in the pediatric field. Pediatric Study Group for Norfloxacin].
Topics: Administration, Oral; Bacterial Infections; Campylobacter Infections; Child; Child, Preschool; Drug | 1990 |
10 other studies available for norfloxacin and Campylobacter Infection
| Article | Year |
|---|---|
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.
Topics: Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Carbapene | 2010 |
Isolation, identification, and antimicrobial susceptibility pattern of Campylobacter jejuni and Campylobacter coli from cattle, goat, and chicken meats in Mekelle, Ethiopia.
Topics: Amoxicillin; Ampicillin; Animals; Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infection | 2021 |
Development of clinically significant resistance to norfloxacin given for Campylobacter diarrhoea.
Topics: Adult; Campylobacter; Campylobacter Infections; Diarrhea; Drug Resistance, Microbial; Female; Humans | 1993 |
Norfloxacin resistance in Campylobacter jejuni and Campylobacter coli isolates from Swedish patients.
Topics: Adult; Anti-Infective Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Ch | 1997 |
Antimicrobial susceptibilities of Campylobacter strains isolated from broilers in the southern part of Japan from 1995 to 1999.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter coli; Campylobacter | 2001 |
Development of resistance to quinolones in five patients with campylobacteriosis treated with norfloxacin or ciprofloxacin.
Topics: Adult; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; DNA, Bacte | 1991 |
[Clinical study on norfloxacin in pediatrics].
Topics: Adolescent; Age Factors; Campylobacter Infections; Child; Child, Preschool; Drug Evaluation; Dysente | 1990 |
Treatment failure of norfloxacin against Campylobacter pylori and chronic gastritis in patients with nonulcerative dyspepsia.
Topics: Campylobacter Infections; Chronic Disease; Dyspepsia; Gastritis; Humans; Norfloxacin | 1989 |
[Clinical study of AM-715 on acute infectious enteritis. The Japan Research Committee of AM-715, Research Group for Acute Infectious Enteritis].
Topics: Acute Disease; Administration, Oral; Campylobacter Infections; Drug Administration Schedule; Dysente | 1986 |
Problems in identification of Campylobacter jejuni associated with acquisition of resistance to nalidixic acid.
Topics: Adult; Bacterial Proteins; Campylobacter fetus; Campylobacter Infections; Drug Resistance, Microbial | 1987 |